Derek Summer®eld in his review of The Medical Profession and Human Rights (August 2001 JRSM, pp. 420±421), uses your respected journal as a forum for his own agenda of hate. As I understand it, Dr Summer®eld was not present when Professor Dolev allegedly made the statement attributed to him. It is unclear to me on what basis Dr Summer®eld allows himself the liberty to cast aspersions on the former head of the IMA ethics committee by attributing to him such a statement, which Professor Dolev vehemently denies having made.
Dr Summer®eld's calumnies, and particularly his decision to publish them in a journal such as yours, lead us to believe that he is less interested in advancing human rights and more interested in slandering and condemning Professor Dolev, the IMA ethics committee and the State of Israel.
We would expect a journal of your calibre to check the facts before you allow them to be printed, and not allow your publication, a medical and not political journal, to be used as a forum for the spewing of lies and vili®cation.
Yoram Blachar
President, Israel Medical Association, PO Box 3604 Ramat-Gan 52136, Israel
Author's reply
A four-member delegation of the Medical Foundation for the Care of Victims of Torture, London (Helen Bamber, Rami Heilbronn, Dr Duncan Forrest, Dr Elizabeth Gordon) can attest that during an interview on 25 November 1999 Professor Dolev said to them that`a couple of broken ®ngers' during the interrogation of Palestinian men was a price worth paying for information. Professor Dolev was then the Head of Ethics of the Israel Medical Association (IMA). This was a moment of honesty which crystallized a position that campaigners had long inferred from the IMA's inactivity on the issue of state torture and the everyday collusion of doctors in the units where this took place. Dr Forrest recorded Professor Dolev's admission last year in a paper in an Amnesty International publication 1 .
The tone and substance of Dr Blachar's letter is sadly familiar to those who have attempted to engage the IMA on these issues over the years: the standard response (when one can be elicited) is that we are motivated by anti-Israeli, and by implication anti-semitic, sentiments. It is worth noting that, in the paper referred to above, Dr Forrest also cited a letter by Dr Blachar in the Israeli newspaper Ha'aretz of 15 November 1999. In it Dr Blachar failed to categorizè moderate physical pressure' as torture (which all human rights organizations have long since condemned as the of®cial euphemism for torture in Israel) and suggested that this might be a suitable response in a`ticking bomb situation' (his words).
This, then, is the quality of ethical leadership available to Israeli doctors. The case against the IMA is the most exhaustively documented of any since that brought fruitfully to bear against the Medical Association of South Africa during the apartheid era.
Derek Summer®eld Mr Britton presents a plausible option for the reorganization of oesophageal cancer services (October 2001 JRSM, pp. 500±501). However, the ®nal sentence undermines the overall plan particularly with respect to the singlehanded or low-volume specialist. The proposed scheme, he says,`does not represent a threat to any specialist in the ®eld provided his or her results withstand local and national review'. A corollary of low caseload volume is that results will be unlikely to be amenable to meaningful statistical review. A large number of years of data will be needed, ensuring a long delay to closure of the audit loop. The way ahead is surely to review operators' processes rather than outcomes of care. Thus, participation in effective prospective audit and multidisciplinary discussion of cases are surely clinical governance issues as valid as, and more timeous than, outcome.
Regular multidisciplinary team discussion has the further advantage of facilitating peer review of management decisions before they are acted on, and thus might effectively form`pre-prospective audit'. The bene®t to both operator and patient is clear: sanctioning of treatment decisions by a responsible body of peers, based on regional as well as local experience. Professor David's editorial is timely (August 2001 JRSM, pp. 373±374). Young disabled people currently get a raw deal, not least because of dif®culty using the healthcare system to their advantage. There are two issues that need to be addressedÐthe transition from a specialist paediatric service to the corresponding adult service 1 ; and the transition of the child with disability or continuing disease to adulthood 2 . The latter is a much more complex task 3 ; whether it can or should be done solely in a hospital specialist clinic is doubtful. Specialist clinics need to be linked with generic services that have a brief to respond.
Designated specialist community teams with this brief have been in existence for over a decade. They are usually led by rehabilitation medicine physicians whose main focus is the disabled adult of working years. These interdisciplinary teams are expert at dealing with the numerous problems of these young people and they work to the young persons' goals. Often the aims include not only educating young persons to manage their own disease and medication but also wider issues such as gaining independence in day-to-day activities (it is not realistic to expect that all, particularly those with neurological disease, can do this on leaving paediatric services) and enabling young persons to structure their own lives and manage their time appropriately.
These interdisciplinary teams may be involved with the young person and his or her family over an extended period (often several years). The latter is important as often the young person with chronic disease may use disengagement from the health system as a mechanism for protest if unable to achieve this by other means. In addition, particularly for those with cognitive and physical problems, acquisition of essential skills may take a long time. This is usually not possible in primary care where focus is often episodic. These teams work¯exibly so that therapeutic intervention can be provided in a variety of settings (at home, at work or in education). This is important in preventing the individual from becoming overdependent on health-based services. The teams establish an extensive network of communication with schools and paediatric services to establish protocols for transfer. They often have open access to their services and cross many interagency boundaries (further education, employers, transport, social services, charitable organizations and so on). Do they work? Informal evidence suggests that the young people engage more in areas such as higher education and employment when such teams are involved. This observation is con®rmed by our recent NHS R&D centrally funded controlled study showing that intervention by interdisciplinary teams with a speci®c remit for the disabled school leaver increase societal participation.
In summary, the rehabilitation medicine physician and specialist young adult services can complement disease-speci®c transitional services set up through paediatrics to help adolescents and young people with disabling chronic diseases ful®l their ambitions. Where shall we send our paper?
Bipin B Bhakta M Anne Chamberlain
I applaud Dr Herxheimer's attempt to encourage authors to make a rational decision about where to send their scienti®c papers (October 2001, JRSM, p. 515). It will certainly be an improvement on the present method which (according to accounts given on our courses) is based on the principle of starting with the journal with the highest impact factor, and then working down. However, I am not sure that Herxheimer's model is the answer. He encourages authors to decide on the basis of where they want to publish; surely a more sensible solution is to decide, using all the available evidence, which journal is most likely to accept the article. Getting a paper published is essentially a sales activity, and the most effective sales people are those who consider the needs of the market rather than their own. 
